To directly compare the effect of CAR-modified T- and NK cells against cervical cancer cells, we isolated primary NK (pPB-NK) and T (pPB-T) cells from PBMCs from the same donors and evaluated CD3 and CD56 expression profiles for NK cells and CD4 and CD8 expression for T cells (Supplementary Figures 12B, C). Here, CD8A is linked to cervical cancer.